LARIMAR THERAPEUTICS, INC.

LRMR ·Healthcare, Drug Manufacturers - General, United States
Financial Statements SEC Filings

SEC Filings

Form Filed Description
4 Mar 2, 2026 4
4 Mar 2, 2026 4
8-K Feb 27, 2026 8-K
424B5 Feb 26, 2026 424B5
424B5 Feb 25, 2026 424B5
8-K Feb 24, 2026 8-K
SCHEDULE 13G/A Feb 17, 2026
SCHEDULE 13G/A Feb 12, 2026
4 Jan 27, 2026 4
4 Jan 27, 2026 4
4 Jan 27, 2026 4
4 Jan 27, 2026 4
8-K Jan 22, 2026 8-K
8-K Jan 12, 2026 8-K
8-K Dec 17, 2025 8-K
8-K Nov 10, 2025 8-K
SCHEDULE 13G/A Nov 6, 2025
10-Q Nov 5, 2025 10-Q
8-K Nov 5, 2025 8-K
8-K Oct 14, 2025 8-K
8-K Sep 29, 2025 8-K
SCHEDULE 13G Aug 29, 2025
10-Q Aug 14, 2025 10-Q
SCHEDULE 13G/A Aug 14, 2025
8-K Aug 14, 2025 8-K
← Newer Page 2 of 28 · 693 filings Older →